June 3, 2020 / 11:38 AM / a month ago

BRIEF-Genscript Files For Emergency Use Authorization Of Rapid Sars-Cov-2 Antibody Detection Kit

June 3 (Reuters) - Genscript Biotech Corp:

* GENSCRIPT FILES FOR EMERGENCY USE AUTHORIZATION OF RAPID SARS-COV-2 NEUTRALIZATION ANTIBODY DETECTION KIT

* GENSCRIPT BIOTECH - HAS FILED FOR EUA WITH U.S. FDA TO MARKET ITS CPASS SARS-COV-2 NEUTRALIZATION ANTIBODY DETECTION KIT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below